发明名称 Combination of compounds that inhibit the biological effects of TNF-alpha and CD95L in a medicament
摘要 The invention relates to medicaments which contain one or more compounds inhibiting the biological effects of TNF-alpha and CD95L, e.g. by blocking the binding of these ligands to their natural receptors thus eliminating signal transduction. These compounds are preferably a neutralizing anti-TNF-alpha antibody and a neutralizing anti-CD95L antibody. The invention also relates to the use of the above compounds for preventing or treating an apoplectic stroke or heart attack.
申请公布号 AU2829001(A) 申请公布日期 2001.06.18
申请号 AU20010028290 申请日期 2000.12.06
申请人 DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECH 发明人 PETER KRAMMER;ANA MARTIN-VILLALBA
分类号 A61K45/00;A61K39/395;A61P7/02;A61P9/00;A61P9/10;A61P19/02;A61P25/16;A61P25/28;A61P43/00;C07K16/24;C07K16/28 主分类号 A61K45/00
代理机构 代理人
主权项
地址